Sec. 6614. Enhanced intelligence community support to secure United States biological data
392 words·~2 min read·
/bill/119/s/1071/eah/section-6614·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Director of National Intelligence, in consultation with such other heads of elements of the intelligence community as the Director considers appropriate, shall provide support to and consult with the Federal Bureau of Investigation, the Committee on Foreign Investment in the United States, and other Federal agencies as appropriate when reviewing transactions relating to the acquisition of covered entities by foreign entities of concern, including attempts by the Government of the People’s Republic of China— to leverage and acquire biological data in the United States; and to leverage and acquire biological data outside the United States, including by providing economic support to the military, industrial, agricultural, or health care infrastructure of foreign countries.
Not later than 90 days after the date of the enactment of this Act, the Director of National Intelligence shall brief the appropriate congressional committees on— a formal process for ensuring intelligence community support to Federal agencies relating to adversary acquisition of biological data, in compliance with Executive Order 14117 ( 50 U.S.C. 1701 note; relating to preventing access to Americans’ bulk sensitive personal data and United States Government-related data by countries of concern), or any successor order; and any additional resources or authorities needed to provide intelligence community support under subsection (b)(1).
In this section: The term appropriate congressional committees means— the congressional intelligence committees; the congressional defense committees (as such term is defined in section 101(a) of title 10, United States Code); the Committee on Foreign Relations, the Committee on the Judiciary, and the Committee on Banking, Housing, and Urban Affairs of the Senate; and the Committee on Foreign Affairs, the Committee on the Judiciary, and the Committee on Financial Services of the House of Representatives.
The term biological data means multiomic information and other relevant information, including associated descriptors, derived from the structure, function, or process of a biological system, that is either measured, collected, or aggregated for analysis, including information from humans, animals, plants, or microbes. The term covered entity means a private entity involved in biological data (including biological data equipment, technologies, sequencing, or synthesis), including a biobank or other private entity that holds large amounts of biological data.
The term foreign entity of concern has the meaning given that term in section 10612(a) of the Research and Development, Competition, and Innovation Act (division B of Public Law 117–167 ; 42 U.S.C. 19221(a) ).
Connectionstraces to 4
Traces to 4 documents
register
U.S. Code
Citation graph
cites case law
Sec. 6614
Enhanced intelligence community support to secure United States biological data
Cites 4Cited by 0 across 0 sources